These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6186267)

  • 1. Human epidermal Langerhans cells are more potent than blood monocytes in inducing some antigen-specific T-cell responses.
    Braathen LR; Thorsby E
    Br J Dermatol; 1983 Feb; 108(2):139-46. PubMed ID: 6186267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on human epidermal langerhans cells. IV. HLA-D restriction of langerhans cell-dependent antigen activation of T lymphocytes.
    Braathen LR; Thorsby E
    Scand J Immunol; 1982 Jan; 15(1):55-61. PubMed ID: 6176017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on human epidermal Langerhans' cells: II. Activation of human T lymphocytes to herpes simplex virus.
    Braathen LR; Berle E; Mobech-Hanssen U; Thorsby E
    Acta Derm Venereol; 1980; 60(5):381-7. PubMed ID: 6162307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enriched epidermal Langerhans cells are potent antigen-presenting cells for T cells.
    Bjercke S; Elgø J; Braathen L; Thorsby E
    J Invest Dermatol; 1984 Oct; 83(4):286-9. PubMed ID: 6090538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Murine epidermal antigen-presenting cells in primary and secondary T-cell proliferative responses to herpes simplex virus in vitro.
    Williams NA; Hill TJ; Hooper DC
    Immunology; 1991 Jan; 72(1):34-9. PubMed ID: 1847693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on human epidermal Langerhans cells III. Induction of T lymphocyte response to nickel sulphate in sensitized individuals.
    Braathen LR
    Br J Dermatol; 1980 Nov; 103(5):517-26. PubMed ID: 6969088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human epidermal Langerhans cells and peripheral blood monocytes. Accessory cell function, autoactivating and alloactivating capacity and ETAF/IL-1 production.
    Räsänen L; Lehto M; Jansén C; Reunala T; Leinikki P
    Scand J Immunol; 1986 Nov; 24(5):503-8. PubMed ID: 3491421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-D/DR restriction of Langerhans cell-dependent antigen activation of T lymphocytes. The same D/DR determinants are restriction elements on monocytes and Langerhans cells.
    Berle EJ; Braathen LR; Thorsby E
    Scand J Immunol; 1982 Dec; 16(6):549-52. PubMed ID: 6186017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunology. Giving credit where credit is due.
    Serbina NV; Pamer EG
    Science; 2003 Sep; 301(5641):1856-7. PubMed ID: 14512609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of short-term corticosteroid incubation on the alloactivating and antigen-presenting capacity of human epidermal Langerhans cells.
    Braathen LR; Hirschberg H
    Br J Dermatol; 1984 Sep; 111(3):295-302. PubMed ID: 6332641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of human epidermal Langerhans cells in skin immunity.
    Braathen LR
    Derm Beruf Umwelt; 1987; 35(2):58-61. PubMed ID: 2439270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The crucial role of human dendritic antigen-presenting cell subsets in nickel-specific T-cell proliferation.
    Res P; Kapsenberg ML; Bos JD; Stiekema F
    J Invest Dermatol; 1987 May; 88(5):550-4. PubMed ID: 2437211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of HLA-Dw1 and -Dw2 positive adherent cells in antigen presentation to heterozygous T-cell lines: a low rubella antigen-specific response associated with HLA-Dw2.
    Ilonen J; Salmi A
    Hum Immunol; 1986 Oct; 17(2):94-101. PubMed ID: 2428786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of class II HLA molecules in T cell activation by antigen. Implications for the autologous mixed lymphocyte reaction.
    Thorsby E; Berle E; Scott H; Braathen LR
    Behring Inst Mitt; 1983 May; (72):129-34. PubMed ID: 6100471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on human epidermal Langerhans cells. I. Allo-activating and antigen-presenting capacity.
    Braathen LR; Thorsby E
    Scand J Immunol; 1980; 11(4):401-8. PubMed ID: 6966818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human rheumatoid synovial and normal blood dendritic cells as antigen presenting cell--comparison with autologous monocytes.
    Waalen K; Førre O; Teigland J; Natvig JB
    Clin Exp Immunol; 1987 Oct; 70(1):1-9. PubMed ID: 2826055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphocyte transformation in nickel allergy: amplification of T-lymphocyte responses to nickel sulphate by macrophages in vitro.
    Silvennoinen-Kassinen S
    Scand J Immunol; 1980; 12(1):61-5. PubMed ID: 6158091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperstimulatory CD1a+CD1b+CD36+ Langerhans cells are responsible for increased autologous T lymphocyte reactivity to lesional epidermal cells of patients with atopic dermatitis.
    Taylor RS; Baadsgaard O; Hammerberg C; Cooper KD
    J Immunol; 1991 Dec; 147(11):3794-802. PubMed ID: 1719088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human T cell response to Herpes simplex virus antigen in vitro.
    Berle EJ; Thorsby E
    Acta Pathol Microbiol Scand C; 1980 Feb; 88(1):31-7. PubMed ID: 6246714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigen presentation in patients with recrudescent orofacial herpes simplex virus infections.
    Vestey JP; Norval M; Howie SE; Maingay JP; Neill W
    Br J Dermatol; 1990 Jan; 122(1):33-42. PubMed ID: 2153401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.